JMDC Inc.
Stock Price Chart
2026/08/05 UpdatedPrice Trend
2026/08/05 UpdatedPrice & Trading Details
2026/08/05 UpdatedPRICE
TRADING
Analyst Recommendations 11 analysts
Updated 2026/08/01Earnings Calendar
Updated 2026/08/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2026/05/07 | ¥35.10 | ¥29.86 | -14.9% |
| 2026/02/04 | ¥35.91 | ¥37.23 | +3.7% |
| 2025/11/05 | ¥24.88 | ¥21.56 | -13.3% |
| 2025/08/06 | ¥12.61 | ¥14.79 | +17.3% |
Shareholder Composition
Updated 2026/08/01Dividend History 4Years Growth
Updated 2026/08/02| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥18 | +12.5% |
| 2025 | ¥16 | +14.3% |
| 2024 | ¥14 | +16.7% |
| 2023 | ¥12 | +20.0% |
| 2022 | ¥10 | - |
Financial Performance
2026/08/02 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥21,814M | ¥27,809M | ¥30,572M | ¥41,722M |
| Gross Profit | ¥12,589M | ¥15,859M | ¥18,171M | ¥23,849M |
| Operating Income | ¥4,784M | ¥5,927M | ¥5,485M | ¥8,718M |
| Pretax Income | ¥4,830M | ¥5,964M | ¥5,501M | ¥8,733M |
| Net Income | ¥3,247M | ¥4,267M | ¥4,607M | ¥7,275M |
| EPS | ¥54.16 | ¥67.69 | ¥69.95 | - |
| Operating Margin | 21.93% | 21.31% | 17.94% | 20.90% |
| Balance Sheet | ||||
| Total Assets | ¥62,053M | ¥98,567M | ¥122,452M | ¥143,020M |
| Total Equity | ¥31,170M | ¥64,539M | ¥70,590M | ¥78,022M |
| Total Liabilities | ¥30,883M | ¥34,028M | ¥51,862M | ¥64,998M |
| Cash | ¥13,192M | ¥22,782M | ¥14,473M | ¥32,176M |
| Interest-bearing Debt | ¥17,795M | ¥20,398M | ¥37,831M | ¥46,888M |
| Equity Ratio | 50.23% | 65.48% | 57.65% | 54.55% |
| D/E Ratio | 0.57 | 0.32 | 0.54 | 0.60 |
| Cash Flow | ||||
| Operating CF | ¥3,808M | ¥4,062M | -¥17M | ¥14,685M |
| Investing CF | -¥8,101M | -¥22,769M | -¥24,864M | -¥3,467M |
| Financing CF | -¥2,414M | ¥28,296M | ¥16,581M | ¥6,484M |
| Free CF | ¥2,486M | ¥2,122M | -¥2,275M | ¥10,992M |
| Efficiency | ||||
| ROE | 10.42% | 6.61% | 6.53% | 9.32% |
| ROA | 5.23% | 4.33% | 3.76% | 5.09% |
Latest IR Information
-
Q1 FY2027 IFRS Consolidated Financial Results (Unaudited) [IFRS] (Consolidated)
Consolidated results for the first quarter of the fiscal year ending March 2027 show net sales of 10,605 million yen, operating income of 1,823 million yen, and net income attributable to owners of the parent of 1,132 million yen. Full-year...
Read more -
Please extract the formal title listed in the PDF and use it as is
Unknown (the PDF excerpt does not include specific financial figures or announcements)
Read more -
[JMD] Stock Option Issuance Details Confirmed｜July 16, 2026
JMD Corporation has resolved to issue a total of 6,540 stock options based on the Board of Directors' resolution on June 25, 2026, with the purpose of issuing 654,000 shares of common stock.
Read more -
[JMDC] Omron, the controlling shareholder, surpasses majority voting rights | June 2026
Omron reports that it has increased its voting rights to over 50%, becoming the parent company. Detailed disclosure of the controlling shareholder status and transaction details as of March 31, 2026.
Read more -
Issuance of Stock Acquisition Rights | Aiming for Mid- to Long-term Business Expansion and Talent Acquisition
JMD Corporation plans to issue a total of 4,350 stock acquisition rights on July 16, 2026, with a maximum of 654,000 shares to be delivered. The purpose is business expansion and talent acquisition, with exercise period from July 1, 2029,...
Read more
Latest News (5 items)
-
Average Analyst Rating: strong_buy
Average Target Price: ¥4,200
Rating Score: 1.45 (Based on 11 analysts)
※1=Strong Buy, 5=Strong Sell
JMDC Finalizes Terms for New Stock Option Grants to Directors and Employees - The Globe and Mail ↗
Company Information
About
JMDC Inc. provides medical statistics data services in Japan. It operates through two segments: Health Big Data and Telemedicine. The company offers big data services for medical field, including WEB tool, analytic, raw data provision, and publication support services; data provision and aggregation, and solution development services; supporting health business for health insurance associations and local government health services; health data platform; and medical institution support services. It also provides JMDC Claims Database, an epidemiological receipt database that has accumulated receipts, including inpatient, outpatient, and dispensing, as well as medical examination data received from multiple health insurance associations. It serves health insurance unions, pharmaceutical companies, life and non-life insurance companies, and research institutions. JMDC Inc. was incorporated in 2002 and is headquartered in Tokyo, Japan. JMDC Inc. is a subsidiary of OMRON Corporation.
